Liver injury caused by ebrotidine: A new example of the utility of the postmarketing surveillance [1]

European Journal of Clinical Pharmacology

Volumn 56, Issue 2, 2000, Pages 187-189

  Castillo, J R ^a   Torello J ^a   Hernandez, A ^b  

^a UNIVERSITY OF SEVILLE   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Ebrotidine; Liver injury; Post marketing surveillance

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; EBROTIDINE;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; DRUG SAFETY; FEMALE; HUMAN; LETTER; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; STOMACH ULCER;

EID: 0034048091     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050739     Document Type: Letter

References (9)